pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,022 catalysts · 7,021 phase readout · 2,430 8k filing · 386 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: recall×type: adcom×clear all
type
  • phase readout7,021
  • 8k filing2,430
  • earnings386
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT06462976: Postoperative Pulmonary Complications in Adult PNL Patients

Sponsor: TC Erciyes University. Phase: . Conditions: Postoperative Pulmonary Complication, Mechanical Power

full page →ctgov ↗
›RECRUITINGphase readoutNCT07102576: MDMA-Assisted Therapy for Mental Healthcare Providers

Sponsor: Rachel Yehuda. Phase: PHASE1. Conditions: Mental Wellbeing

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07639476: Study on Mental Health Promoting Effects of Natural Psychotherapy for Adolescents

Sponsor: Beijing HuiLongGuan Hospital. Phase: NA. Conditions: Anxiety Disorders, Depressive Disorder, Mental Health

full page →ctgov ↗
›COMPLETEDphase readoutNCT04430517: Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia

Sponsor: Mclean Hospital. Phase: EARLY_PHASE1. Conditions: Mild Cognitive Impairment, Mild Alzheimer Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05852717: Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Sponsor: Dipenkumar Modi. Phase: PHASE2. Conditions: Large Cell Lymphoma, Diffuse, Relapsed Cancer, Refractory Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04472117: PREPARE: Patient Centered Perioperative Experience

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Minimally Invasive Surgery (MIS) Hysterectomy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07364617: Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD

Sponsor: Chang Gung Memorial Hospital. Phase: PHASE2. Conditions: Graft vs Host Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05040217: A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment

Sponsor: Mark Tuszynski. Phase: PHASE1. Conditions: Alzheimer's Disease, Mild Cognitive Impairment

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07568717: Healing Together: Partners' Experiences in the Journey of Sexual Trauma Recovery Through the Intervention Take Your Sexuality Back for Sexually Traumatized Women.

Sponsor: Sykehuset Telemark. Phase: NA. Conditions: Sexual Abuse, Posttraumatic Stress Symptom, Sexual Trauma, Partner

full page →ctgov ↗
›COMPLETEDphase readoutNCT07194317: A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment

Sponsor: King's College London. Phase: NA. Conditions: Obese Patients

full page →ctgov ↗
›RECRUITINGphase readoutNCT07437417: A Novel Volume Stable Matrix for Gingival Recession Coverage at Teeth

Sponsor: University of Bern. Phase: NA. Conditions: Gingival Recession, Connective Tissue Defect

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06635694: naVIGation Invitations Liver surveillANce upTake

Sponsor: Imperial College London. Phase: . Conditions: Hepatocellular Carcinoma, Liver Cirrhosis, Chronic Hep B

full page →ctgov ↗
›COMPLETEDphase readoutNCT06657456: Impact of Phytosterol-Rich Extract on Lipid Profile

Sponsor: Desirée Victoria Montesinos. Phase: NA. Conditions: Cholesterol, Elevated, Hypercholesterolaemia, Lipid Metabolism Disorders, Dyslipidemias

full page →ctgov ↗
›RECRUITINGphase readoutNCT05662722: Percutaneous Needle Electrolysis (PNE) on the Concha of the Ear

Sponsor: University of Alcala. Phase: NA. Conditions: Headache

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04443829: Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma

Sponsor: University College, London. Phase: PHASE1. Conditions: Primary CNS Lymphoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06617429: Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)

Sponsor: Ultragenyx Pharmaceutical Inc. Phase: PHASE3. Conditions: Angelman Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07515131: Respiratory Function and S-index in Radiographic Axial Spondyloarthritis

Sponsor: Gazi University. Phase: . Conditions: Radiographic Axial Spondyloarthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06161402: Elastic Band-Progressive Resistance Training (EB-PRT) for Sarcopenia Among Heart Failure Patients

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Heart Failure

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07639853: Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils

Sponsor: Medtronic Endovascular. Phase: . Conditions: Arteriovenous Malformation, Gastrointestinal Bleed, Gastric Varices, Hemorrhoid, Pelvic Venous Disorders, Peripheral Aneurysms, Portal Vein Embolization, Type II Endoleak, Varicocele, Hemorrhage

full page →ctgov ↗
›COMPLETEDphase readoutNCT06080737: Long Term Effects of Awake Prone Positioning in COVID-19 ICU Patients

Sponsor: University Hospital, Tours. Phase: . Conditions: SARS-CoV 2 Pneumonia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06434337: Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Human Papillomavirus

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05203445: A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07701772: LASER VERSUS CRYSTALLIZED PHENOL IN PILONIDAL SINUS DISEASE

Sponsor: Sanliurfa Education and Research Hospital. Phase: NA. Conditions: Sacrococcygeal Pilonidal Sinus Disease, Pilonidal Sinus Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT06648772: Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Plaque Psoriasis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07767695: ChatGPT-Supported Metacognitive Feedback in Nursing Students

Sponsor: Izmir Katip Celebi University. Phase: NA. Conditions: Metacognitive Awareness and Self-Regulated Learning in Nursing Students

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07277595: kTMP in Chronic Stroke

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Stroke, Chronic Stroke Patients, Arm Weakness as a Consequence of Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT06904495: Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Cancer Survivors

full page →ctgov ↗
›COMPLETEDphase readoutNCT07404995: Analgesic Efficacy of Bilateral Erector Spinae Plane Block in Pediatric Tethered Cord Syndrome Surgery

Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital. Phase: NA. Conditions: Erector Spina Plan Block

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07415577: The Use of Cultured (Dermal) Epithelial Autografts in Severely Burned Patients

Sponsor: University Children's Hospital, Zurich. Phase: . Conditions: Burn Degree Second, Burn Degree Third, Skin Transplantation, Full Thickness Skin Defects

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07565701: Safety and Efficacy of a Phased Transition From Epogen to Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Subjects Receiving In-Center Hemodialysis

Sponsor: Geoff Block. Phase: PHASE3. Conditions: Anemia Associated With Chronic Kidney Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07028112: Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Iron Overload, Hemosiderosis, Liver Diseases, Hematopoietic Stem Cell Transplantation (HSCT)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07775781: Effectiveness of Implementing a Reablement Model in Community-Based Long-Term Care Centers

Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Elderly, Long-Term Care, Reablement, Activities of Daily Living

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07692581: A Clinical Trial to Evaluate the Effects of Larineco Remineralizing Gum on Oral Health, Breath Freshness, Tooth Sensitivity, and Gum Comfort

Sponsor: Larine C Corporation. Phase: NA. Conditions: Bad Breath, Tooth Sensitivity

full page →ctgov ↗
›COMPLETEDphase readoutNCT06310681: Pilot Testing of a Co-adapted Group Programme for Parents/Carers of Children With Complex Neurodisability

Sponsor: City, University of London. Phase: NA. Conditions: Complex Neurodevelopmental Disorder, Cerebral Palsy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07530081: The Impact of Oral Probiotics on Improving the Quality of Life in Patients With Dysmenorrhea.

Sponsor: Glac Biotech Co., Ltd. Phase: NA. Conditions: Dysmenorrhea

full page →ctgov ↗
›RECRUITINGphase readoutNCT00542230: Blood Sampling for Research Related to Sickle Cell Disease

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Sickle Cell Trait, Sickle Cell Disease, Sickle Cell Anemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05703230: Effects of Preoperative Multidisciplinary Team Meetings for High-risk, Adult, Noncardiac Surgical Patients

Sponsor: Rijnstate Hospital. Phase: NA. Conditions: Interdisciplinary Communication, Postoperative Complications, Noncardiac Surgery, Surgical Procedures, Operative, Preoperative Care, Patient Care Team, Cost-Benefit Analysis, Comorbidities and Coexisting Conditions

full page →ctgov ↗
›COMPLETEDphase readoutNCT07604857: Combined Oral and Parenteral Nutritional Therapy After Gastrectomy for Gastric Cancer

Sponsor: Kyo Young Song. Phase: NA. Conditions: Gastric Cancer (GC), Malnutitrion

full page →ctgov ↗
›RECRUITINGphase readoutNCT06173401: Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

Sponsor: Stanford University. Phase: PHASE3. Conditions: Spinal Metastases

full page →ctgov ↗
›RECRUITINGphase readoutNCT04888481: 68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors

Sponsor: University of Alberta. Phase: PHASE2. Conditions: Neuroendocrine Tumors

full page →ctgov ↗
›TERMINATEDphase readoutNCT03114319: Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC), KRAS G12-mutant NSCLC, Esophageal Squamous Cell Cancer (SCC), Head/Neck SCC, Melanoma, Advanced Gastrointestinal Stromal Tumors (GIST), Advanced NRAS/BRAFT wt Cutaneous Melanoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06793930: A Tailored, Optimised, and Person-centred Programme to Promote Lifestyle Modification in People With Metabolic Syndrome

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Metabolic Syndrome, Primary Prevention of Atherosclerotic Cardiovascular Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07421830: An Empowering Parent Training Intervention to Increase Physical Activity in Preschool Aged Children With Autism

Sponsor: Northeastern University. Phase: NA. Conditions: Autism Spectrum Disorder (ASD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04639830: Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations

Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Healthy Children, Children With Neurodevelopmental Disorders, Children With Neuropsychiatric Disorders, Children With Behavioral Syndromes

full page →ctgov ↗
›COMPLETEDphase readoutNCT05742165: Time Restricted Eating for Weight Loss Maintenance

Sponsor: NYU Langone Health. Phase: NA. Conditions: Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT04375267: 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours

Sponsor: Vastra Gotaland Region. Phase: PHASE1. Conditions: Clinical Trial, Phase I, Neuroendocrine Tumors, Thymoma, Mesothelioma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06318767: Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Major Adverse Limb Events, Major Adverse Cardiovascular Events, Peripheral Artery Disease, Critical Limb Ischemia, Hemodynamic Measure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07748000: A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks

Sponsor: Liquidia Technologies, Inc.. Phase: PHASE2. Conditions: Raynaud's Phenomenon Secondary to Systemic Sclerosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07627100: COMPARISON OF AIRWAY NERVE BLOCK VERSUS NEBULIZED LIDOCAINE ON HEMODYNAMIC RESPONSES DURING AWAKE FIBEROPTIC INTUBATION

Sponsor: Mayo Hospital Lahore. Phase: NA. Conditions: Blood Pressure After Nerve Block, Hemodynamic Stability During Awake Intubation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07515300: Impact of the ARM Technique on the Prevention of Lymphedema After Axillary Lymphadenectomy: A Multicenter Randomized Clinical Trial

Sponsor: Hospital Universitari de Bellvitge. Phase: NA. Conditions: Breast Cancer, Lymphedema Arm

full page →ctgov ↗
← prev
page 135 of 141
next →